Metroticket 2.0

Metroticket 2.0 combines tumour size and number with AFP. Within these limits, predicted 5-year HCC-specific survival after transplant is about 70% or more. Use the largest viable tumour and number of tumours on the last imaging before transplant, and the AFP at that time.

Results

In ng/mL. If your laboratory reports kIU/L (IU/mL), multiply by 1.21.

Enter the values above.

Limits

AFP (ng/mL)Number of tumours + largest diameter (cm)
Under 2007 or less
200 to 4005 or less
401 to 1,0004 or less
Over 1,000Outside the criteria

Reference

Mazzaferro V, Sposito C, Zhou J, et al. Metroticket 2.0 model for analysis of competing risks of death after liver transplantation for hepatocellular carcinoma. Gastroenterology. 2018;154(1):128-139.